Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
6.70
-0.04 (-0.59%)
May 28, 2025, 4:00 PM - Market closed
Neuphoria Therapeutics Employees
As of June 30, 2024, Neuphoria Therapeutics had 24 total employees, including 8 full-time and 16 part-time employees.
Employees
24
Change
n/a
Growth
n/a
Revenue / Employee
$652,613
Profits / Employee
$242,792
Market Cap
12.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NEUP News
- 1 day ago - Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting - GlobeNewsWire
- 8 days ago - Neuphoria Provides First Quarter 2025 Business Updates - GlobeNewsWire
- 6 weeks ago - Neuphoria Provides a Review of 2024 and Highlights 2025 Plans - GlobeNewsWire
- 3 months ago - Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025 - GlobeNewsWire
- 3 months ago - Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - GlobeNewsWire
- 5 months ago - Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq - GlobeNewsWire